Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

M-1774 demonstrates potent antitumor activity both as monotherapy and in combination

April 22, 2022

MRT-2359 shows promise for Myc-driven solid tumors

April 22, 2022

Dual adenosine receptor A2A/A2B antagonist M-1069 reduces tumor growth in vivo

April 21, 2022

Medshine Discovery synthesizes PRMT5 inhibitors

April 21, 2022

Wigen Biomedicine Technology presents new GTPase KRAS inhibitors

April 21, 2022

CSPC Zhongqi Pharmaceutical Technology patents new ATM inhibitors

April 21, 2022

AUR-103 in combination with azacytidine and bortezomib for myeloma and leukemia treatment

April 20, 2022

Shanghai Visonpharma synthesizes new TLR7 agonists

April 20, 2022

Medshine Discovery identifies new CSF-1R inhibitors

April 20, 2022

CSPC Zhongqi Pharmaceutical Technology divulges salts of tyrosine kinase inhibitors

April 20, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...